M. Koretz

A comparison of the quality of participation of community affiliates and that of universities in the Northern California Oncology Group.

F. Torti, S. Carter, M. Koretz, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adaptive randomization biased coin design: Experience in a cooperative group clinical trial

B. Efron, J. Hannigan, B. W. Brown, 1980 .

Treatment of refractory chronic lymphocytic leukemia with prednimustine: A phase II study using strict response criteria

D. Gandara, Jerry P. Lewis, C. George, 2004, Cancer Chemotherapy and Pharmacology.

Adverse reactions to AMSA in medical personnel.

F. Torti, R. Ignoffo, R. Reynolds, 1982, Cancer treatment reports.

AMSA--a promising new agent in refractory acute leukemia.

F. Torti, J. P. Lewis, H. J. Lawrence, 1982, Cancer treatment reports.

Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.

B. Sikic, S. Ballon, M. Koretz, 1985, Cancer treatment reports.

A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts

D. Gandara, S. Carter, J. P. Lewis, 2004, Cancer Chemotherapy and Pharmacology.

Granulocytic sarcoma of the chest wall at site of Hickman catheter tract.

S. Ariad, G. Pizov, M. Koretz, 1996, Leukemia & lymphoma.

Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.

R. Carlson, B. Sikic, V. Picozzi, 1985, Cancer treatment reports.